Manufactures cellular immunotherapeutics in order to treat cancer and infectious diseases
Cell Medica has raised €99M across 5 funding rounds from 3 investors, most recently a Series B round in Nov 2014. Based in London, UK; founded 2006; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors |
|---|
| 2014-11-01 | Series B | €64M | Imperial Innovations Limited,Invesco Perpetual,Woodford Investment Management | View deal → |
| 2012-07-01 | Other | €24M | — | View deal → |
| 2009-12-01 | Other | €2.0M | — | View deal → |
| 2009-09-01 | Other | €6.6M | — | View deal → |
| 2007-03-01 | Other | €3.4M | — | View deal → |
